Daewoong Pharmaceutical Co., Ltd

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:54,814 tCO2eq/year (2022)

Scope 1 Emissions:14,528 tCO2eq/year (2022)

Scope 2 Emissions:40,286 tCO2eq/year (2022)

Scope 3 Emissions:Not disclosed

Renewable Energy Share:Not disclosed

Total Energy Consumption:1,156,894 GJ/year (2022)

Water Consumption:550,067 tons/year (2022)

Waste Generated:18,293 tons/year (2022)

Carbon Intensity:2.98 tCO2eq/100 million KRW (2022)

ESG Focus Areas

Research and Development and Innovation
Drug Safety and Quality Enhancement
Securing Talent and Improving Organizational Culture
Climate Change Response
Environmental Impact Minimization
Eco-friendly Products
Human Rights
Ethical Management in the Medical Industry
Sustainable Supply Chain Management
Workplace Safety and Health
Environmental Conservation around the Workplace
Environmental Resource Management
Stakeholder Communication and Disclosure Enhancement

Environmental Achievements

Reduced energy consumption costs by approximately 6.6 billion KRW from 2012 to 2022.
Achieved 100% LED lighting conversion in factories.
Reduced energy consumption by 5% year-on-year.
Reduced water usage by 26.50 ton/100 million KRW compared to 2021.
Improved water reuse rate by 6.53% in 2022.
Reduced CO2 emissions by 2.98 tCO2eq/100 million KRW in 2022.
Achieved 95% recycling rate for hazardous waste in 2022.
Reduced HPDE plastic emissions by 1.85 tons in 2022.

Social Achievements

Zero findings in the Korea Ministry of Food and Drug Safety's GCP inspections for product approvals and changes in 2022.
Achieved 100% compliance in submitting reports on time in 2022.
Won a silver award at the 2022 National Quality Control Circle Competition.
Implemented a job-based pay system in 2017.
Employee engagement increased for three consecutive years (2020-2022).
Received GPTW's Best Workplace certification in 2022.
Selected as the top family-friendly company in the pharmaceutical industry in 2022.
Donated 831 million KRW worth of medicines and health functional foods in 2022.
Consistently increased the recycling rate of hazardous waste for three consecutive years.

Governance Achievements

Acquired ISO 37001 certification for anti-corruption management system in 2018 and renewed in 2021.
Acquired ISO 27001 and ISO 27701 certifications for information security and personal information protection management systems in 2022.
Board attendance rate of 83.3% for inside directors and 81.3% for outside directors in 2022.

Climate Goals & Targets

Long-term Goals:

Not disclosed

Medium-term Goals:

Not disclosed

Short-term Goals:

Not disclosed

Environmental Challenges

Securing talented professionals.
Climate change response.
Strengthening drug safety and quality.
Human rights.
Ethical management in the medical industry.
Sustainable supply chain management.
Workplace safety and health.
Environmental conservation around the workplace.
Environmental resource management.
Stakeholder communication and disclosure enhancement.
Eco-friendly drug production and packaging.

Mitigation Strategies

Continuous recruitment of new and experienced employees.
Implementation of a job-based pay system.
CDP system for diverse experience opportunities.
Establishment of an energy-saving TF.
Implementation of ISO 14001 certification.
Development of eco-friendly materials with partners.
Establishment of a drug surveillance system.
Implementation of a quality management system.
Establishment of human rights policies and guidelines.
Implementation of an anti-corruption management system (ISO 37001).
Establishment of a supplier risk management process.
Implementation of ISO 45001 certification.
Regular inspections and improvements of hazardous chemical handling facilities.
Implementation of a Green Supply Chain management system.
Development of eco-friendly drug materials.
Reduction of waste through removal of cushioning materials, simplification of containers, and removal of paper inserts.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

Fair and transparent supplier selection process.
Regular audits to ensure quality and minimize risks.
Collaboration with suppliers on eco-friendly materials.

Climate-Related Risks & Opportunities

Physical Risks

Extreme weather events

Transition Risks

Regulatory changes

Opportunities

Development of energy-efficient products

Reporting Standards

Frameworks Used: GRI Standards 2021, SASB Standards, UN SDGs

Certifications: ISO 14001, ISO 45001, ISO 37001, ISO 27001, ISO 27701

Third-party Assurance: Korea Standards Association

UN Sustainable Development Goals

Goal 3: Good Health and Well-being
Goal 8: Decent Work and Economic Growth
Goal 9: Industry, Innovation and Infrastructure
Goal 12: Responsible Consumption and Production
Goal 13: Climate Action
Goal 17: Partnerships for the Goals

Initiatives aligned with these goals are described throughout the report.

Sustainable Products & Innovation

Eco-friendly drug materials
Eco-friendly packaging

Awards & Recognition

2022 GPTW Best Workplace
2022 Top Family-Friendly Company
2022 THE ESG Award
2022 Korea PR Award
2022 Social Contribution Company Award
2022 Love Sharing Social Contribution Award
2022 National Quality Control Circle Competition Silver Award

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:32,971 tCO2e/year (Scope 1+2)

Scope 1 Emissions:9,675 tCO2e/year

Scope 2 Emissions:23,296 tCO2e/year